Rani Therapeutics Holdings, Inc. (RANI) NASDAQ

0.55

+0.0038(+0.69%)

Updated at August 18 04:00PM

Currency In USD

Valuation

Market Cap39.01M
Enterprise Value64.96M
P/E Ratio-0.68
PEG Ratio-0.08
Price/Sales Ratio33.69
Price/Book Ratio-3.63
Enterprise/Revenue41.33
Enterprise/EBITDA-1.03

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-24.74
Operating Margin-41.06

Management Effectiveness

Return On Assets-1.76
Return On Equity33.74

Income Statement

Revenue1.03M
Revenue/Share0.03
Gross Profit1.03M
EBITDA-50.52M
Net Income-30.02M
Diluted EPS-1.05

Balance Sheet

Total Cash10.22M
Total Cash/Share0.28
Total Debt19.39M
Total Debt/Equity-3.48
Current Ratio0.54
Book Value Per Share-0.25

Price History

52-Week Change-80.64
52-Week High3.75
52-Week Low0.39
Moving Average 50 Days0.53
Moving Average 200 Days1.23

Statistics

Average Volume1.83M
Shares Outstanding72.99M
% Held by Institutions17.66

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A